Jose A. Madrazo

Jose A. Madrazo

Cardiology
601 North Caroline Street
Suite 7200
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Clinical Spectrum and Outcomes in Hypertrophic Cardiomyopathy With Apical Aneurysms: A Large Multicenter International Cohort.

Clinical Spectrum and Outcomes in Hypertrophic Cardiomyopathy With Apical Aneurysms: A Large Multicenter International Cohort.

Journal: JACC. Advances
Published: January 25, 2026

New and recurrent atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy receiving mavacamten.

New and recurrent atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy receiving mavacamten.

Journal: Heart rhythm
Published: January 13, 2026

Left Ventricular Hypertrophy With Pre-Excitation: Thinking Beyond the Usual Hypertrophic Cardiomyopathy Diagnosis.

Left Ventricular Hypertrophy With Pre-Excitation: Thinking Beyond the Usual Hypertrophic Cardiomyopathy Diagnosis.

Journal: JACC. Case reports
Published: January 12, 2026

Recurrent rash over a cardiac implantable electronic device: A rare case of antibacterial envelope hypersensitivity.

Recurrent rash over a cardiac implantable electronic device: A rare case of antibacterial envelope hypersensitivity.

Journal: HeartRhythm case reports
Published: December 03, 2025

Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.

Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.

Journal: Journal of cardiac failure
Published: October 16, 2025

Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.

Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.

Journal: medRxiv : the preprint server for health sciences
Published: September 26, 2025

Early Diastolic Release Flow Is a Sensitive Early Marker for Left Ventricular Apical Aneurysm in Patients with Hypertrophic Cardiomyopathy.

Early Diastolic Release Flow Is a Sensitive Early Marker for Left Ventricular Apical Aneurysm in Patients with Hypertrophic Cardiomyopathy.

Journal: CJC open
Published: September 25, 2025

Pregnancy Management and Outcomes with Hypertrophic Cardiomyopathy.

Pregnancy Management and Outcomes with Hypertrophic Cardiomyopathy.

Journal: CJC open
Published: July 25, 2025

External validation of atrial fibrillation risk prediction tools in a racially diverse cohort of patients with hypertrophic cardiomyopathy.

External validation of atrial fibrillation risk prediction tools in a racially diverse cohort of patients with hypertrophic cardiomyopathy.

Journal: Heart rhythm
Published: March 07, 2025

Management of Cardiac Amyloidosis With Concomitant Left Ventricular Outflow Tract Obstruction.

Management of Cardiac Amyloidosis With Concomitant Left Ventricular Outflow Tract Obstruction.

Journal: JACC. Case reports
Published: February 03, 2025

Concurrent Use of Tafamidis and Mavacamten for Transthyretin Cardiac Amyloidosis With Severe Outflow Tract Obstruction.

Concurrent Use of Tafamidis and Mavacamten for Transthyretin Cardiac Amyloidosis With Severe Outflow Tract Obstruction.

Journal: JACC. Case reports
Published: January 15, 2025

Conservative Management of Left Atrial Dissection and Associated Complete Heart Block Following Cardiac Surgery.

Conservative Management of Left Atrial Dissection and Associated Complete Heart Block Following Cardiac Surgery.

Journal: JACC. Case reports
Published: October 15, 2024
Showing 1-12 of 28

Last Updated: 09/26/2026